To further validate our hypothesis, we added MMP-2 selective inhibitor I(sc-204092, Santa Cruz) at the same time of PinX1 siRNA transfecting into ccRCC cells. This evidence concerns the gene PINX1 and nonpapillary renal cell carcinoma.